As Bitcoin (BTC) price signals a potential rebound beyond $90k soon, Dogecoin (DOGE), the leading dog-themed memecoin secured via the proof-of-work (PoW) consensus method, has hinted at possible bottoming. Since March 11, Dogecoin price has rebounded over 15 percent to trade at about $0.1721.
Dogecoin price has depicted a high correlation with Bitcoin price, thus likely to rebound in the near future. Moreover, the crypto market is bound to significantly benefit from the easing yields in the U.S. bond market amid the ongoing bull rally for gold.
Dogecoin Price Expectations
From a technical analysis standpoint, Dogecoin price has been forming a macro rising trend, characterized by higher highs and higher lows. After a notable decline since the second inauguration of U.S. President Donald Trump, Dogecoin price has been retesting the lower border of a rising channel in the past two weeks.
In the daily time frame, Dogecoin price has been forming an ascending triangle, after being trapped in a parallel falling trend. As a result, a consistent close above the resistant level around $0.178 will result in a 15-20 percent spike in the coming days to retest the upper border of the falling logarithmic trend.
However, a consistent close below 16 cents could trigger further sell-off towards the next target of about 14 cents.
Fundamental Outlook
Dogecoin has grown to a vibrant memecoin ecosystem backed by institutional investors participating in mining processes and global merchants accepting it for payments. As of this writing, the Dogecoin network has about 6.2 million on-chain holders.
According to on-chain data analysis, the Dogecoin network has recorded a significant spike in whale activities during the last week. In the past week, Dogecoin investors with an account balance of between 1 million and 10 million added around 110 million coins to currently hold about 10.44 billion.
Meanwhile, the number of active addresses on the Dogecoin network has doubled in the past few weeks to about 280k at the time of this writing.
By Ayelet Richter, Business Development Expert and AI Business Consultant
The technological and industrial revolutions have always worked hand in hand. The breakneck speed at which technology is evolving today is contributing to consistent breakthroughs, especially in the areas of health and finance. As innovators in the tech and healthcare space deftly navigate the complexities of transforming industries, the investment landscape also begins to shift. The obvious similarities between cryptocurrency and AI are opening the door for wild potential in the future and enhancing opportunities for investors.
Advancements and challenges in the AI revolution
While artificial intelligence (AI) is not a new discovery, its role in the healthcare space is novel. AI is revolutionizing spaces such as drug discovery and drug development, data collection and interpretation, and efficiency improvement in all areas of the pharma industry. AI-driven solutions are still in their relative infancy for healthcare applications, but their potential is already crystal clear concerning improving efficiency, reducing failure rates, and accelerating the time-to-market for new drugs.
Integrating AI technology into the pharma sector can be a complex undertaking, presenting several challenges for those on the front lines of AI innovation. Regulatory and compliance guidelines have not always kept pace with discovery, leading to unnecessary hurdles in the rollout of new drugs and processes. Data availability, quality, and security may be lacking. Pharmaceutical data is often fragmented across different institutions, creating accessibility barriers. Data privacy regulations like HIPAA and GDPR also limit the availability of real-world patient data for AI training. This is where blockchain technology can assist the emergence of effective AI in healthcare. By leveraging federated learning, AI models can be trained across decentralized data sources without compromising privacy.
Investment in AI models can also be met with skepticism. Many AI models function as black boxes, making it difficult for regulators and pharma executives to trust their recommendations. Lack of interpretability in AI-driven drug discovery models can create distrust in clinical and regulatory environments.
Cost is a significant barrier to AI implementation in healthcare. AI integration requires substantial investment in infrastructure, talent acquisition, and computational power. Training AI models on biomedical data is expensive and requires access to cloud computing resources, GPUs, and specialized algorithms. Pharma companies may hesitate to invest in AI without immediate financial returns. To combat this issue, many are turning to cost-effective AI-as-a-Service (AIaaS) models, allowing pharma companies to use AI solutions without massive upfront investment, exploring public-private partnerships, and grant funding to support AI-driven research in pharma, or leveraging pre-trained AI models and transfer learning techniques to reduce training costs.
Crypto investment and AI
With AI poised to redefine the healthcare landscape, it is no wonder cryptocurrency investors have a keen interest in the technology. The interwoven nature of blockchain technology and healthcare AI applications for security and efficiency appeals to the burgeoning crypto market. While overcoming the mentioned challenges in AI integration will be critical for market application success, catering to the investment interests of crypto investors will also be significant in the overall adoption of AI in the pharma space.
Advancements in AI in the pharma sector have led to an uptick in venture capital investment, strengthening the trust muscle of other interested parties, such as crypto investors. According to a recent study, 38% of new investment dollars allocated for healthcare are directed towards AI-enabled technologies. The validity of AI partnerships and the necessity of AI assistance in pharma development and discovery efficiency have driven investment. The convergence of AI and cryptocurrency is already emerging through crypto, such as AxonDAO ($AXGT) and Welshare Health ($WEL), creating opportunities for crypto investors to enter the space.
The currently available advancements of AI in the pharma sector are just the tip of the iceberg. Investors should be aware of the exponential growth potential in healthcare AI. As innovators navigate the myriad of hurdles on the pathway to full adoption — such as regulatory matters and investor skepticism — they continue to make welcomed advancements in the space. Crypto investors are likely to play a crucial role in the future adoption of AI in healthcare. As investor trust in AI in the pharma space b
The post Investments in AI: Revolutionizing the Pharmaceutical Industry’s Future appeared first on Coinpedia Fintech News
By Ayelet Richter, Business Development Expert and AI Business Consultant The technological and industrial revolutions have always worked hand in hand. The breakneck speed at which technology is evolving today is contributing to consistent breakthroughs, especially in the areas of health and finance. As innovators in the tech and healthcare space deftly navigate the complexities …
New York-based legal firm Burwick Law filed a class action lawsuit against the main parties involved in LIBRA, the Argentinian meme coin scandal. The lawsuit specifically targets KIP, Meteora, and Kelsier, but not President Javier Milei.
Over the past few months, the firm has filed several lawsuits against meme coin projects. It alleges serious financial misconduct from all these parties.
Yesterday, Burwick filed another class-action lawsuit, this time centered around the LIBRA meme coin.
“Tonight, our firm filed a class action complaint in the Supreme Court of New York on behalf of our client. We allege that Kelsier, KIP, Meteora, and related parties orchestrated an unfair token launch (LIBRA), allegedly misleading purchasers and harming retail investors,” the firm claimed via social media.
Essentially, Burwick accuses several parties involved with LIBRA of “deceptive, manipulative, and fundamentally unfair” conduct. These people artificially inflated the token’s price and then caused a collapse—otherwise known as pump-and-dump.
Surprisingly, the suit does not name Argentine President Javier Milei as a defendant. In addition to being a significant political figure, Milei also downplayed his direct connections to the debacle.
Instead of targeting him, Burwick’s lawsuit is going after the private companies that directly facilitated the LIBRA launch: KIT, Meteora, and Kelsier.
“The complaint details how, according to our allegations, one-sided liquidity pools were used to artificially inflate LIBRA’s price. We further allege that approximately 85% of supply was withheld at launch, enabling insiders to profit while everyday buyers bore the losses,” Burwick Law stated.
Who Were the Culprits Behind the LIBRA Scandal?
The initial name behind the LIBRA meme coin launch was KIP Protocol, a Web3 AI base layer. However, the firm completely distanced itself from any rug pull allegations.
KIP claimed that it did not launch or profit from LIBRA and that it was only asked “to assist in managing the project’s financing initiative.” The other firms, however, have much clearer connections.
Meteora, a decentralized crypto exchange, was thoroughly involved in LIBRA. The company’s co-founder resigned in the immediate aftermath but maintained his innocence.
Notably, Meteora’s reputation was already damaged by the TRUMP meme coin. This small exchange was the first platform to host the token, which increased its TVL by over 300% in days to over $1.9 billion.
Kelsier Ventures, LIBRA’s market maker, seems especially vulnerable to lawsuits. In a shocking interview, CEO Hayden Davis defended his actions, admitting to past scams and claiming he did nothing out of the ordinary.
Davis was in talks to launch a similar meme coin with the Nigerian government and was recently tied to a Wolf of Wall Street-themed meme coin. It’s no wonder that Davis, of all the names involved with the whole scandal, is the only person with an active arrest warrant against him.
Additionally, data engineer Fernando Molina alleged that these parties tried to launch two other Argentina-centric tokens before LIBRA. A few telltale fingerprints connect it with ARG and MILEI, such as shared wallets, liquidity pools, and timing. Molina suggested that LIBRA’s creators could’ve created these assets as test coins, but isn’t certain.
Assets Possibly Launched By LIBRA Team. Source: Fernando Molina
There are quite a few unanswered questions about the whole LIBRA scandal, and it’s unclear how they’ll play into the lawsuit. Hopefully, investigations can help clear up some of the biggest mysteries.
After all, political meme coin schemes like this can damage the reputation of the whole industry. So, the current lawsuit from Burwick might be in everyone’s best interest.
As we enter Q2 of 2025, the global crypto market finds itself steering a complex intersection of macroeconomic and geopolitical pressures.
BeInCrypto spoke with analysts Leena ElDeeb of 21Shares and Max Shannon of CoinShares, who offer distinct but insightful perspectives on the crypto space’s outlook for the new quarter.
Bitcoin’s Future: Bullish or Bearish?
The two analysts share a bullish outlook on Bitcoin, albeit with differing views on its short-term fluctuations. Leena ElDeeb sees the potential for Bitcoin to surpass $90,000, driven by macroeconomic factors such as a possible rate cut by the US Federal Reserve.
“February’s softer-than-expected CPI print boosted rate cut expectations. If rate cuts materialize, a wave of liquidity could reignite bullish momentum, pushing equities and Bitcoin past key resistance levels,” she told BeInCrypto.
In her view, Bitcoin could eventually hit a range between $150,000 and $200,000 by the year’s end, bolstered by growing regulatory clarity and political support, such as President Trump’s proposal for a strategic crypto reserve.
Max Shannon, on the other hand, remains more cautious about Bitcoin’s immediate future. He predicts that Bitcoin will continue to trade within a wide range of $70,000 to $90,000 in Q2, constrained by persistent tariff issues.
“The moment they [tariffs] get lifted will likely be a massive boon for the equities and crypto market,” he notes, indicating that a resolution could pave the way for Bitcoin’s next big move.
Both analysts acknowledge Ethereum’s struggles, particularly its nearly 40% drop in Q1. However, they also highlight key developments that could support a recovery in the next quarter.
ElDeeb points to Ethereum’s upcoming upgrade, the Pectra upgrade, which is expected to improve staking and network scalability.
“Ethereum’s staking is also about to be improved with the launch of Pectra. These changes are expected to boost the appeal of staking-enabled products,” she explained.
Additionally, she sees growing competition from other blockchain platforms like Solana and Sui, which are attracting retail users with faster and cheaper transactions. Despite this, ElDeeb remains optimistic about Ethereum’s long-term potential, particularly as scalability solutions begin to take effect.
Shannon is more skeptical of Ethereum’s future, specifically with its ongoing challenges in both the monetary and smart contract spaces.
“Ethereum is attempting to function both as a monetary asset, where it struggles to compete with Bitcoin, and as a smart contract platform, where it faces strong competition from Solana,” the CoinShares analyst stated.
Shannon also highlights Ethereum’s changing monetary policy and the increasing technical debt as concerns that could limit its growth in the short term.
The rise and fall of celebrity meme coins like TRUMP, MELANIA, and LIBRA were hot topics in Q1 2025. Both analysts agree that the hype around this category of tokens is unlikely to be sustained in the long run.
“The forthcoming cryptocurrency market rally is anticipated to be driven by significant advancements in decentralized finance (DeFi), particularly through innovative mechanisms that enhance token holder engagement,” she notes, citing Aave’s recent proposal to share revenue with AAVE token holders as a prime example of this trend.
On the flip side, Shannon suggests that the decline in meme coins and altcoins could be a sign of broader challenges in the altcoin market.
“The Melei controversy, pump.fun decline, and declining centralized and decentralized exchange volumes show altcoins could have a very hard time this year in my opinion,” he cautions.
As trading volumes continue to drop, Shannon forecasts that altcoins may continue to underperform.
“Even in a BTC bull run altcoins could underperform,” the analyst added.
The Road Ahead
Looking ahead to Q2 2025, both ElDeeb and Shannon anticipate continued market volatility. External macroeconomic conditions like US tariffs, interest rate decisions, and geopolitical factors will largely shape the market.
While ElDeeb maintains a generally optimistic view, predicting a recovery for both Bitcoin and Ethereum, Shannon advises caution, particularly with altcoins.
For investors, diversification remains key. ElDeeb emphasizes the value of Bitcoin’s fixed supply and decentralization, which have historically helped it recover from turbulent periods.
“We consider these market corrections as great market entry points,” she says.
Shannon, meanwhile, stressed the importance of caution in navigating the altcoin space. He added that Bitcoin could be the best bet for those seeking stability.
